Clinical trial
Characteristics and 6-month Outcomes Among Real-World Rheumatoid Arthritis Patients Initiating Inflectra
NCT05375942 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characteristics and 6-month Outcomes Among Real-World Rheumatoid Arthritis Patients Initiating Inflectra
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 11, 2022
- Completion date
- November 11, 2022
- Enrollment
- 255 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.